~~<i id='F2B2164B2E'><strike id='F2B2164B2E'><tt id='F2B2164B2E'><pre id='F2B2164B2E'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：entertainment 2025-10-02 08:27:12 Page View：98

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Unmasking the 'centricity' illusion in clinical trials
Next article： Supreme Court strikes down use of affirmative action

explore

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Protect nursing home residents from future pandemics

AcleaningcrewwearingprotectiveclothingtakesdisinfectingequipmentintoanursinghomeintheSeattlesuburbsf

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

AdobeWhenitcomestobringinganexperimentaldrugtomarketandsellingit,NovoNordisk,themakeroftheweightloss

WSS

explore

explore

knowledge

explore

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers